The value of inhaled β2-agonists in patients with acute bronchitis is unclear and any potential benefit remains unproven. (Two small randomized controlled trials [RCTs] using different agents reached different conclusions.) Beta-agonists may have a role in patients with acute bronchitis who are wheezing. (SOR C, based on expert opinion and subanalysis of an RCT).

URI:

http://hdl.handle.net/10355/7755

Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.